{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:26:13Z","timestamp":1787185573913,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01686-4","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T18:08:26Z","timestamp":1779818906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic hormone and adipokine alterations in major depressive disorder in relation to the acute-phase inflammatory response and early-life adversity"],"prefix":"10.1038","volume":"6","author":[{"given":"Tangcong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7667-6731","authenticated-orcid":false,"given":"Abbas F.","family":"Almulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Kubera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"1686_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41582-025-01116-4","volume":"21","author":"M Maes","year":"2025","unstructured":"Maes, M., Almulla, A. F., You, Z. & Zhang, Y. Neuroimmune, metabolic and oxidative stress pathways in major depressive disorder. Nat. Rev. Neurol. 21, 473\u2013489 (2025).","journal-title":"Nat. Rev. Neurol."},{"key":"1686_CR2","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/neu.2025.10044","volume":"38","author":"AF Almulla","year":"2025","unstructured":"Almulla, A. F., Niu, M., Stoyanov, D., Zhang, Y. & Maes, M. Monomeric CRP and negative acute phase proteins, but not pentameric CRP, as biomarkers of major depression and MDMD. Acta Neuropsychiatr. 38, e4 (2025).","journal-title":"Acta Neuropsychiatr."},{"key":"1686_CR3","doi-asserted-by":"publisher","unstructured":"Maes, M. et al. The negative acute phase response and not serum C-reactive protein is a major biomarker of major depression: a precision nomothetic psychiatry study. https:\/\/doi.org\/10.1101\/2025.08.15.25333787 (2025).","DOI":"10.1101\/2025.08.15.25333787"},{"key":"1686_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.bbi.2023.08.007","volume":"113","author":"AF Almulla","year":"2023","unstructured":"Almulla, A. F. et al. Reverse cholesterol transport and lipid peroxidation biomarkers in major depression and bipolar disorder: A systematic review and meta-analysis. Brain Behav. Immun. 113, 374\u2013388 (2023).","journal-title":"Brain Behav. Immun."},{"key":"1686_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2025.106005","volume":"169","author":"K Jirakran","year":"2025","unstructured":"Jirakran, K. et al. Increased atherogenicity in mood disorders: a systematic review, meta-analysis and meta-regression. Neurosci. Biobehav Rev. 169, 106005 (2025).","journal-title":"Neurosci. Biobehav Rev."},{"key":"1686_CR6","doi-asserted-by":"publisher","unstructured":"Chen, T. C. et al. The acute phase inflammatory response as a key determinant of reduced lipid-associated antioxidant defenses in Chinese patients with major depressive disorder. https:\/\/doi.org\/10.1101\/2025.10.08.25337557 (2025).","DOI":"10.1101\/2025.10.08.25337557"},{"key":"1686_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jad.2014.09.038","volume":"172","author":"SO Nunes","year":"2015","unstructured":"Nunes, S. O. et al. Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder. J. Affect Disord. 172, 55\u201362 (2015).","journal-title":"J. Affect Disord."},{"key":"1686_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jad.2021.07.057","volume":"294","author":"NR Morelli","year":"2021","unstructured":"Morelli, N. R. et al. Increased nitro-oxidative toxicity in association with metabolic syndrome, atherogenicity and insulin resistance in patients with affective disorders. J. Affect Disord. 294, 410\u2013419 (2021).","journal-title":"J. Affect Disord."},{"key":"1686_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pnpbp.2017.04.027","volume":"78","author":"LGP de Melo","year":"2017","unstructured":"de Melo, L. G. P. et al. Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 78, 34\u201350 (2017).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"1686_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104758","volume":"139","author":"BS Fernandes","year":"2022","unstructured":"Fernandes, B. S. et al. Insulin resistance in depression: a large meta-analysis of metabolic parameters and variation. Neurosci. Biobehav Rev. 139, 104758 (2022).","journal-title":"Neurosci. Biobehav Rev."},{"key":"1686_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jad.2017.07.010","volume":"222","author":"K Landucci Bonif\u00e1cio","year":"2017","unstructured":"Landucci Bonif\u00e1cio, K. et al. Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers. J. Affect Disord. 222, 185\u2013194 (2017).","journal-title":"J. Affect Disord."},{"key":"1686_CR12","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.17305\/bb.2024.11800","volume":"25","author":"ZY Xu","year":"2025","unstructured":"Xu, Z. Y. et al. Association between triglyceride-glucose (TyG) index and risk of depression in middle-aged and elderly Chinese adults: evidence from a large national cohort study. Biomol. Biomed. 25, 1621\u20131630 (2025).","journal-title":"Biomol. Biomed."},{"key":"1686_CR13","doi-asserted-by":"publisher","unstructured":"Luo, Y. Y. et al. Lower insulin resistance in Chinese patients with severe major depressive disorder: associations with the inflammatory response. https:\/\/doi.org\/10.1101\/2025.10.10.25337709 (2025).","DOI":"10.1101\/2025.10.10.25337709"},{"key":"1686_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/mp.2010.52","volume":"16","author":"RC Shelton","year":"2011","unstructured":"Shelton, R. C. et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol. Psychiatry 16, 751\u2013762 (2011).","journal-title":"Mol. Psychiatry"},{"key":"1686_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jad.2018.05.008","volume":"238","author":"B Cao","year":"2018","unstructured":"Cao, B. et al. Leptin and adiponectin levels in major depressive disorder: a systematic review and meta-analysis. J. Affect Disord. 238, 101\u2013110 (2018).","journal-title":"J. Affect Disord."},{"key":"1686_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.neulet.2006.08.043","volume":"407","author":"R Leo","year":"2006","unstructured":"Leo, R. et al. Decreased plasma adiponectin concentration in major depression. Neurosci. Lett. 407, 211\u2013213 (2006).","journal-title":"Neurosci. Lett."},{"key":"1686_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.biopsych.2012.03.010","volume":"72","author":"SJ Spencer","year":"2012","unstructured":"Spencer, S. J. et al. Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress. Biol. Psychiatry 72, 457\u2013465 (2012).","journal-title":"Biol. Psychiatry"},{"key":"1686_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.psyneuen.2014.11.013","volume":"52","author":"DA Wittekind","year":"2015","unstructured":"Wittekind, D. A. & Kluge, M. Ghrelin in psychiatric disorders - a review. Psychoneuroendocrinology 52, 176\u2013194 (2015).","journal-title":"Psychoneuroendocrinology"},{"key":"1686_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.9758\/cpn.2023.21.1.147","volume":"21","author":"SH Lee","year":"2023","unstructured":"Lee, S. H. et al. Plasminogen activator inhibitor-1: potential inflammatory marker in late-life depression. Clin. Psychopharmacol. Neurosci. 21, 147\u2013161 (2023).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"1686_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-016-0272-9","volume":"17","author":"PC Li","year":"2016","unstructured":"Li, P. C., Liu, L. F., Jou, M. J. & Wang, H. K. The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice. BMC Neurosci. 17, 37 (2016).","journal-title":"BMC Neurosci."},{"key":"1686_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/mp.2012.144","volume":"18","author":"F Lamers","year":"2013","unstructured":"Lamers, F. et al. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol. Psychiatry 18, 692\u2013699 (2013).","journal-title":"Mol. Psychiatry"},{"key":"1686_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jad.2014.10.010","volume":"172","author":"EI Fried","year":"2015","unstructured":"Fried, E. I. & Nesse, R. M. Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study. J. Affect Disord. 172, 96\u2013102 (2015).","journal-title":"J. Affect Disord."},{"key":"1686_CR23","doi-asserted-by":"publisher","unstructured":"Mengqi Niu, Y. Z. et al. Dissection of the clinical phenome of major depressive disorder into subdomains and subgroups in relation to activated immune-inflammatory profiles. https:\/\/doi.org\/10.1101\/2025.10.21.25338439 (2025).","DOI":"10.1101\/2025.10.21.25338439"},{"key":"1686_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.116085","volume":"339","author":"M Maes","year":"2024","unstructured":"Maes, M. et al. The recurrence of illness (ROI) index is a key factor in major depression that indicates increasing immune-linked neurotoxicity and vulnerability to suicidal behaviors. Psychiatry Res. 339, 116085 (2024).","journal-title":"Psychiatry Res."},{"key":"1686_CR25","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1007\/s12035-019-1552-z","volume":"56","author":"M Maes","year":"2019","unstructured":"Maes, M. et al. Development of a novel staging model for affective disorders using partial least squares bootstrapping: effects of lipid-associated antioxidant defenses and neuro-oxidative stress. Mol. Neurobiol. 56, 6626\u20136644 (2019).","journal-title":"Mol. Neurobiol."},{"key":"1686_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/archpsyc.65.4.409","volume":"65","author":"A Danese","year":"2008","unstructured":"Danese, A. et al. Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch. Gen. Psychiatry 65, 409\u2013415 (2008).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1686_CR27","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1007\/s12035-019-1498-1","volume":"56","author":"G Morris","year":"2019","unstructured":"Morris, G., Berk, M., Maes, M., Carvalho, A. F. & Puri, B. K. Socioeconomic deprivation, adverse childhood experiences and medical disorders in adulthood: mechanisms and associations. Mol. Neurobiol. 56, 5866\u20135890 (2019).","journal-title":"Mol. Neurobiol."},{"key":"1686_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1475-7","volume":"16","author":"CH Liu","year":"2019","unstructured":"Liu, C. H. et al. Role of inflammation in depression relapse. J. Neuroinflammation 16, 90 (2019).","journal-title":"J. Neuroinflammation"},{"key":"1686_CR29","first-page":"115","volume":"46","author":"M Maes","year":"2025","unstructured":"Maes, M. et al. Key factors underpinning neuroimmune-metabolic-oxidative (NIMETOX) major depression in outpatients: paraoxonase 1 activity, reverse cholesterol transport, increased atherogenicity, protein oxidation, and differently expressed cytokine networks. Neuro Endocrinol. Lett. 46, 115\u2013125 (2025).","journal-title":"Neuro Endocrinol. Lett."},{"key":"1686_CR30","doi-asserted-by":"publisher","unstructured":"Maes, M. et al. Adverse childhood experiences predict the phenome of affective disorders and these effects are mediated by staging, neuroimmunotoxic and growth factor profiles. Cells 11 https:\/\/doi.org\/10.3390\/cells11091564 (2022).","DOI":"10.3390\/cells11091564"},{"key":"1686_CR31","doi-asserted-by":"publisher","first-page":"e65356","DOI":"10.1371\/journal.pone.0065356","volume":"8","author":"L Gu","year":"2013","unstructured":"Gu, L. et al. Epidemiology of major depressive disorder in mainland China: a systematic review. PLoS ONE 8, e65356 (2013).","journal-title":"PLoS ONE"},{"key":"1686_CR32","doi-asserted-by":"publisher","first-page":"e052457","DOI":"10.1136\/bmjopen-2021-052457","volume":"12","author":"X Xu","year":"2022","unstructured":"Xu, X. et al. Prevalence of metabolic syndrome among the adult population in western China and the association with socioeconomic and individual factors: four cross-sectional studies. BMJ Open 12, e052457 (2022).","journal-title":"BMJ Open"},{"key":"1686_CR33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/2047487314525529","volume":"22","author":"A Scuteri","year":"2015","unstructured":"Scuteri, A. et al. Metabolic syndrome across Europe: different clusters of risk factors. Eur. J. Prev. Cardiol. 22, 486\u2013491 (2015).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"1686_CR34","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2020.4501","volume":"323","author":"G Hirode","year":"2020","unstructured":"Hirode, G. & Wong, R. J. Trends in the prevalence of metabolic syndrome in the United States, 2011-2016. JAMA 323, 2526\u20132528 (2020).","journal-title":"JAMA"},{"key":"1686_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","volume":"9","author":"XF Pan","year":"2021","unstructured":"Pan, X. F., Wang, L. & Pan, A. Epidemiology and determinants of obesity in China. Lancet Diab. Endocrinol. 9, 373\u2013392 (2021).","journal-title":"Lancet Diab. Endocrinol."},{"key":"1686_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000528083","volume":"16","author":"M Hassapidou","year":"2023","unstructured":"Hassapidou, M. et al. European Association for the Study of Obesity Position Statement on Medical Nutrition Therapy for the Management of Overweight and Obesity in Adults Developed in collaboration with the European Federation of the Associations of Dietitians. Obes. Facts 16, 11\u201328 (2023).","journal-title":"Obes. Facts"},{"key":"1686_CR37","unstructured":"Hales, C. M., Carroll, M. D., Fryar, C. D. & Ogden, C. L. Prevalence of obesity and severe obesity among adults: United States, 2017-2018. NCHS Data Brief, 360, 1\u20138 (2020)."},{"key":"1686_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1365658","volume":"15","author":"C Zhou","year":"2024","unstructured":"Zhou, C. et al. Positive association between blood ethylene oxide levels and metabolic syndrome: NHANES 2013-2020. Front. Endocrinol. 15, 1365658 (2024).","journal-title":"Front. Endocrinol."},{"key":"1686_CR39","doi-asserted-by":"publisher","unstructured":"Almulla, A. F. & Maes, M. Peripheral immune-inflammatory pathways in major depressive disorder, bipolar disorder, and schizophrenia: exploring their potential as treatment targets. CNS Drugs https:\/\/doi.org\/10.1007\/s40263-025-01195-3 (2025).","DOI":"10.1007\/s40263-025-01195-3"},{"key":"1686_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-021-03647-8","volume":"22","author":"J Cao","year":"2022","unstructured":"Cao, J. et al. The association between serum albumin and depression in chronic liver disease may differ by liver histology. BMC Psychiatry 22, 5 (2022).","journal-title":"BMC Psychiatry"},{"key":"1686_CR41","doi-asserted-by":"publisher","unstructured":"Maes, A. F. et al. Monomeric CRP and negative acute phase proteins but not pentameric CRP are biomarkers of major depression and especially major dysmood disorder. https:\/\/doi.org\/10.13140\/RG.2.2.29231.60328 (2025).","DOI":"10.13140\/RG.2.2.29231.60328"},{"key":"1686_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2174\/0929866023408779","volume":"9","author":"F Ceciliani","year":"2002","unstructured":"Ceciliani, F., Giordano, A. & Spagnolo, V. The systemic reaction during inflammation: the acute-phase proteins. Protein Pept. Lett. 9, 211\u2013223 (2002).","journal-title":"Protein Pept. Lett."},{"key":"1686_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1515\/REVNEURO.1993.4.4.407","volume":"4","author":"M Maes","year":"1993","unstructured":"Maes, M. A review on the acute phase response in major depression. Rev. Neurosci. 4, 407\u2013416 (1993).","journal-title":"Rev. Neurosci."},{"key":"1686_CR44","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1097\/01.mcg.0000155514.17715.39","volume":"39","author":"M Chojkier","year":"2005","unstructured":"Chojkier, M. Inhibition of albumin synthesis in chronic diseases: molecular mechanisms. J. Clin. Gastroenterol. 39, S143\u2013S146 (2005).","journal-title":"J. Clin. Gastroenterol."},{"key":"1686_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0165-0327(91)90032-N","volume":"23","author":"M Maes","year":"1991","unstructured":"Maes, M. et al. Anthropometric and biochemical assessment of the nutritional state in depression: evidence for lower visceral protein plasma levels in depression. J. Affect Disord. 23, 25\u201333 (1991).","journal-title":"J. Affect Disord."},{"key":"1686_CR46","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2147\/PRBM.S458257","volume":"17","author":"A Vasupanrajit","year":"2024","unstructured":"Vasupanrajit, A., Maes, M., Jirakran, K. & Tunvirachaisakul, C. Complex intersections between adverse childhood experiences and negative life events impact the phenome of major depression. Psychol. Res Behav. Manag. 17, 2161\u20132178 (2024).","journal-title":"Psychol. Res Behav. Manag."},{"key":"1686_CR47","doi-asserted-by":"crossref","unstructured":"Almulla, A. F. et al. C-reactive protein is not a biomarker of depression severity in drug-na\u00efve obese patients with metabolic syndrome. Acta Neuropsychiatr. 38, 1-43 (2025).","DOI":"10.1017\/neu.2025.10034"},{"key":"1686_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-025-06734-2","volume":"25","author":"K Jirakran","year":"2025","unstructured":"Jirakran, K. et al. Lipid profiles in major depression, both with and without metabolic syndrome: associations with suicidal behaviors and neuroticism. BMC Psychiatry 25, 379 (2025).","journal-title":"BMC Psychiatry"},{"key":"1686_CR49","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/CIRCRESAHA.121.318093","volume":"128","author":"M Koenen","year":"2021","unstructured":"Koenen, M., Hill, M. A., Cohen, P. & Sowers, J. R. Obesity, adipose tissue and vascular dysfunction. Circ. Res. 128, 951\u2013968 (2021).","journal-title":"Circ. Res."},{"key":"1686_CR50","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1161\/ATVBAHA.108.170316","volume":"28","author":"CM Apovian","year":"2008","unstructured":"Apovian, C. M. et al. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler. Thromb. Vasc. Biol. 28, 1654\u20131659 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1686_CR51","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.2337\/db05-1404","volume":"55","author":"AL Carey","year":"2006","unstructured":"Carey, A. L. et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55, 2688\u20132697 (2006).","journal-title":"Diabetes"},{"key":"1686_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jad.2016.04.047","volume":"200","author":"E Salagre","year":"2016","unstructured":"Salagre, E., Fernandes, B. S., Dodd, S., Brownstein, D. J. & Berk, M. Statins for the treatment of depression: a meta-analysis of randomized, double-blind, placebo-controlled trials. J. Affect Disord. 200, 235\u2013242 (2016).","journal-title":"J. Affect Disord."},{"key":"1686_CR53","first-page":"49","volume":"50","author":"R Colle","year":"2017","unstructured":"Colle, R. et al. PPAR-\u03b3 agonists for the treatment of major depression: a review. Pharmacopsychiatry 50, 49\u201355 (2017).","journal-title":"Pharmacopsychiatry"},{"key":"1686_CR54","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.pnpbp.2017.08.024","volume":"81","author":"M Sowa-Ku\u0107ma","year":"2018","unstructured":"Sowa-Ku\u0107ma, M. et al. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts. Prog. Neuropsychopharmacol. Biol. Psychiatry 81, 372\u2013383 (2018).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"1686_CR55","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.2174\/1381612827666210603145441","volume":"27","author":"VV Tarasov","year":"2021","unstructured":"Tarasov, V. V. et al. Biological mechanisms of atypical and melancholic major depressive disorder. Curr. Pharm. Des. 27, 3399\u20133412 (2021).","journal-title":"Curr. Pharm. Des."},{"key":"1686_CR56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jad.2009.02.005","volume":"118","author":"J Thuile","year":"2009","unstructured":"Thuile, J., Even, C., Musa, C., Friedman, S. & Rouillon, F. Clinical correlates of atypical depression and validation of the French version of the Scale for Atypical Symptoms (SAS). J. Affect Disord. 118, 113\u2013117 (2009).","journal-title":"J. Affect Disord."},{"key":"1686_CR57","doi-asserted-by":"publisher","unstructured":"Musil, R. et al. Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder. Int. J. Methods Psychiatr. Res. 27 https:\/\/doi.org\/10.1002\/mpr.1569 (2018).","DOI":"10.1002\/mpr.1569"},{"key":"1686_CR58","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jad.2018.12.020","volume":"246","author":"LM Xin","year":"2019","unstructured":"Xin, L. M. et al. Prevalence and clinical features of atypical depression among patients with major depressive disorder in China. J. Affect Disord. 246, 285\u2013289 (2019).","journal-title":"J. Affect Disord."},{"key":"1686_CR59","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2025.2608029","author":"M Maes","year":"2025","unstructured":"Maes, M., Almulla, A. F., Stoyanov, D. & Zhang, Y. Advancements in the molecular understanding of major depressive disorder uncovering novel targets with therapeutic promise: focus on recurrence of illness. Expert Opin. Ther. Targets https:\/\/doi.org\/10.1080\/14728222.2025.2608029 (2025).","journal-title":"Expert Opin. Ther. Targets"},{"key":"1686_CR60","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0145-2134(02)00541-0","volume":"27","author":"DP Bernstein","year":"2003","unstructured":"Bernstein, D. P. et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abus. Negl. 27, 169\u2013190 (2003).","journal-title":"Child Abus. Negl."},{"key":"1686_CR61","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti, K. G. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640\u20131645 (2009).","journal-title":"Circulation"},{"key":"1686_CR62","first-page":"205","volume":"45","author":"HK Al-Hakeim","year":"2023","unstructured":"Al-Hakeim, H. K. et al. Increased insulin resistance due to Long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection. Braz. J. Psychiatry 45, 205\u2013215 (2023).","journal-title":"Braz. J. Psychiatry"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01686-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01686-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01686-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:02:50Z","timestamp":1787184170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01686-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1686"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01686-4","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"446"}}